A detailed history of Black Rock Inc. transactions in Celcuity Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,459,553 shares of CELC stock, worth $18.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,459,553
Previous 1,111,856 31.27%
Holding current value
$18.3 Million
Previous $24 Million 0.45%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$14.1 - $20.78 $4.9 Million - $7.23 Million
347,697 Added 31.27%
1,459,553 $23.9 Million
Q1 2024

May 10, 2024

BUY
$13.74 - $21.6 $844,529 - $1.33 Million
61,465 Added 5.85%
1,111,856 $24 Million
Q4 2023

Feb 13, 2024

BUY
$8.7 - $15.02 $773,142 - $1.33 Million
88,867 Added 9.24%
1,050,391 $15.3 Million
Q3 2023

Nov 13, 2023

BUY
$8.96 - $10.75 $435,025 - $521,934
48,552 Added 5.32%
961,524 $8.79 Million
Q2 2023

Aug 11, 2023

BUY
$9.39 - $12.18 $7.35 Million - $9.53 Million
782,486 Added 599.67%
912,972 $10 Million
Q1 2023

May 12, 2023

BUY
$9.4 - $12.82 $788,556 - $1.08 Million
83,889 Added 180.03%
130,486 $1.34 Million
Q4 2022

Feb 13, 2023

SELL
$7.55 - $14.01 $6,123 - $11,362
-811 Reduced 1.71%
46,597 $652,000
Q3 2022

Nov 14, 2022

SELL
$8.0 - $10.64 $13,952 - $18,556
-1,744 Reduced 3.55%
47,408 $477,000
Q2 2022

Aug 12, 2022

SELL
$5.35 - $10.11 $2.16 Million - $4.08 Million
-403,962 Reduced 89.15%
49,152 $447,000
Q1 2022

May 12, 2022

SELL
$7.93 - $13.33 $58,007 - $97,508
-7,315 Reduced 1.59%
453,114 $4.24 Million
Q4 2021

Feb 10, 2022

BUY
$11.96 - $19.35 $333,385 - $539,381
27,875 Added 6.44%
460,429 $6.07 Million
Q3 2021

Nov 09, 2021

BUY
$17.35 - $24.87 $941,705 - $1.35 Million
54,277 Added 14.35%
432,554 $7.79 Million
Q2 2021

Aug 11, 2021

BUY
$14.25 - $30.93 $5.39 Million - $11.7 Million
378,277 New
378,277 $9.08 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $187M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.